Stay updated on Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.5.5 is now displayed, replacing Revision: v3.5.4. This indicates a minor site version update to the platform's metadata with no changes to study content.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page's revision indicator was updated from v3.5.3 to v3.5.4, representing a minor, internal update to the ClinicalTrials.gov page rather than a modification to study data or visible content.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page’s footer “Revision” version was increased from v3.5.2 to v3.5.3, indicating a backend/software release update without changing the study information presented.SummaryDifference0.1%

- Check54 days agoChange DetectedAddition: Revision v3.5.2; Deletion: Revision v3.5.0.SummaryDifference0.1%

- Check83 days agoChange DetectedThe site footer revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check90 days agoChange DetectedThe site revision displayed changed from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page.